Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series.

Wang JW, Wang YK, Zhang F, Su YC, Wang JY, Wu DC, Hsu WH.

Kaohsiung J Med Sci. 2019 Jun 14. doi: 10.1002/kjm2.12094. [Epub ahead of print]

2.

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial.

Chiang HH, Wu DC, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Yao CC, Tsai CE, Liang CM, Wang YK, Wang JW, Huang CF, Chuah SK; Taiwan Acid-Related Disease Study Group.

Drug Des Devel Ther. 2019 Apr 26;13:1347-1356. doi: 10.2147/DDDT.S193559. eCollection 2019.

3.

Risks of substance uses, alcohol flush response, Helicobacter pylori infection and upper digestive tract diseases-An endoscopy cross-sectional study.

Chuang YS, Wu MC, Wang YK, Chen YH, Kuo CH, Wu DC, Wu MT, Wu IC.

Kaohsiung J Med Sci. 2019 Jun;35(6):341-349. doi: 10.1002/kjm2.12071. Epub 2019 Apr 18.

4.

Influence of Tea Consumption on the Development of Second Esophageal Neoplasm in Patients with Head and Neck Cancer.

Wang YK, Chen WC, Lai YH, Chen YH, Wu MT, Kuo CT, Wang YY, Yuan SF, Liu YP, Wu IC.

Cancers (Basel). 2019 Mar 19;11(3). pii: E387. doi: 10.3390/cancers11030387.

5.

Helicobacter pylori Infection-Induced Hepatoma-Derived Growth Factor Regulates the Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells.

Liu CJ, Wang YK, Kuo FC, Hsu WH, Yu FJ, Hsieh S, Tai MH, Wu DC, Kuo CH.

Cancers (Basel). 2018 Nov 30;10(12). pii: E479. doi: 10.3390/cancers10120479.

6.

Fecal microbiota transplantation: Review and update.

Wang JW, Kuo CH, Kuo FC, Wang YK, Hsu WH, Yu FJ, Hu HM, Hsu PI, Wang JY, Wu DC.

J Formos Med Assoc. 2019 Mar;118 Suppl 1:S23-S31. doi: 10.1016/j.jfma.2018.08.011. Epub 2018 Sep 1. Review.

7.

Insights into the management of gastric antral vascular ectasia (watermelon stomach).

Hsu WH, Wang YK, Hsieh MS, Kuo FC, Wu MC, Shih HY, Wu IC, Yu FJ, Hu HM, Su YC, Wu DC.

Therap Adv Gastroenterol. 2018 Jan 14;11:1756283X17747471. doi: 10.1177/1756283X17747471. eCollection 2018. Review.

8.

Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases.

Wang YK, Chiang WC, Kuo FC, Wu MC, Shih HY, Wang SSW, Liu CJ, Chen YH, Wu DC, Su WW, Huang YL.

Helicobacter. 2018 Apr;23(2):e12460. doi: 10.1111/hel.12460. Epub 2018 Jan 5.

PMID:
29315971
9.

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.

Liang CM, Kuo MT, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK; Taiwan Acid-Related Disease Study Group.

World J Gastroenterol. 2017 Dec 21;23(47):8395-8404. doi: 10.3748/wjg.v23.i47.8395.

10.

Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.

Kung YM, Hsu WH, Wu MC, Wang JW, Liu CJ, Su YC, Kuo CH, Kuo FC, Wu DC, Wang YK.

Dig Dis Sci. 2017 Dec;62(12):3298-3316. doi: 10.1007/s10620-017-4830-5. Epub 2017 Nov 6. Review.

PMID:
29110162
11.

Effects of alcohol consumption, cigarette smoking, and betel quid chewing on upper digestive diseases: a large cross-sectional study and meta-analysis.

Chuang YS, Wu MC, Yu FJ, Wang YK, Lu CY, Wu DC, Kuo CT, Wu MT, Wu IC.

Oncotarget. 2017 Sep 11;8(44):78011-78022. doi: 10.18632/oncotarget.20831. eCollection 2017 Sep 29.

12.

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori.

Wu MC, Wang YK, Liu CJ, Yu FJ, Kuo FC, Liu ML, Kuo CH, Wu DC, Huang YK, Wu IC.

Gastroenterol Res Pract. 2017;2017:5320180. doi: 10.1155/2017/5320180. Epub 2017 Jul 16.

13.

Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.

Wang YK, Chuang YS, Wu TS, Lee KW, Wu CW, Wang HC, Kuo CT, Lee CH, Kuo WR, Chen CH, Wu DC, Wu IC.

Int J Cancer. 2017 Nov 15;141(10):1987-1996. doi: 10.1002/ijc.30911. Epub 2017 Aug 9.

14.

Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.

Hsu PI, Tsai FW, Kao SS, Hsu WH, Cheng JS, Peng NJ, Tsai KW, Hu HM, Wang YK, Chuah SK, Chen A, Wu DC.

Am J Gastroenterol. 2017 Sep;112(9):1374-1381. doi: 10.1038/ajg.2017.195. Epub 2017 Jul 18.

PMID:
28719592
15.

Diagnosis of Helicobacter pylori infection: Current options and developments.

Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK, Wu DC.

World J Gastroenterol. 2015 Oct 28;21(40):11221-35. doi: 10.3748/wjg.v21.i40.11221. Review.

16.

Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient.

Wang YK, Hwang DY, Wang SS, Hwang SJ, Chen LT, Kuo MC.

Kaohsiung J Med Sci. 2013 Dec;29(12):691-4. doi: 10.1016/j.kjms.2013.08.003. Epub 2013 Sep 10.

17.

Current pharmacological management of gastroesophageal reflux disease.

Wang YK, Hsu WH, Wang SS, Lu CY, Kuo FC, Su YC, Yang SF, Chen CY, Wu DC, Kuo CH.

Gastroenterol Res Pract. 2013;2013:983653. doi: 10.1155/2013/983653. Epub 2013 Jun 26.

Supplemental Content

Loading ...
Support Center